However, another study showed that CCDC50 maintains long-term activation of NF-κB signaling in Fas-stimulated thymocytes [22], and CCDC50 is required for tumor survival and activates NF-κB signaling in CLL and MCL [13]. This evidence concerns the gene CCDC50 and B-cell chronic lymphocytic leukemia.